Transduction profiles of recombinant adeno-associated virus vectors derived from serotypes 2 and 5 in the nigrostriatal system of rats

被引:77
作者
Paterna, JC
Feldon, J
Büeler, H
机构
[1] Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland
[2] ETH, Lab Behav Neurobiol, CH-8603 Schwerzenbach, Switzerland
关键词
D O I
10.1128/JVI.78.13.6808-6817.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We compared the transduction efficiencies and tropisms of titer-matched recombinant adeno-associated viruses (rAAV) derived from serotypes 2 and 5 (rAAV-2 and rAAV-5, respectively) within the rat nigrostriatal system. The two serotypes (expressing enhanced green fluorescent protein [EGFP]) were delivered by stereotaxic surgery into the same animals but different hemispheres of the striatum (STR), the substantia nigra (SN), or the medial forebrain bundle (MFB). While both serotypes transduced neurons effectively within the STR, rAAV-5 resulted in a much larger EGFP-expressing area than did rAAV-2. However, neurons transduced with rAAV-2 vectors expressed higher levels of EGFP. Consistent with this result, EGFP-positive projections emanating from transduced striatal neurons covered a larger area of the SN pars reticulata (SNr) after striatal delivery of rAAV-5, but EGFP levels in fibers of the SNr were higher after striatal injection of rAAV-2. We also compared the potentials of the two vectors for retrograde transduction and found that striatal delivery of rAAV-5 resulted in significantly more transduced dopaminergic cell bodies within the SN pars compacta and ventral tegmental area. Similarly, EGFP-transduced striatal neurons were detected only after nigral delivery of rAAV-5. Furthermore, we demonstrate that after striatal AAV-5 vector delivery, the transduction profiles were stable for as long as 9 months. Finally, although we did not target the hippocampus directly, efficient and widespread transduction of hippocampal neurons was observed after delivery of rAAV-5, but not rAAV-2, into the MFB.
引用
收藏
页码:6808 / 6817
页数:10
相关论文
共 55 条
[21]   Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity [J].
Kaludov, N ;
Brown, KE ;
Walters, RW ;
Zabner, J ;
Chiorini, JA .
JOURNAL OF VIROLOGY, 2001, 75 (15) :6884-6893
[22]   Targeted retrograde gene delivery for neuronal protection [J].
Kaspar, BK ;
Erickson, D ;
Schaffer, D ;
Hinh, L ;
Gage, FH ;
Peterson, DA .
MOLECULAR THERAPY, 2002, 5 (01) :50-56
[23]   Long-term rAAV-mediated gene transfer of GDNF in the rat parkinson's model:: Intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system [J].
Kirik, D ;
Rosenblad, C ;
Björkland, A ;
Mandel, RJ .
JOURNAL OF NEUROSCIENCE, 2000, 20 (12) :4686-4700
[24]   Reversal of motor impairments in parkinsonian rats by continuous intrastriatal delivery of L-dopa using rAAV-mediated gene transfer [J].
Kirik, D ;
Georgievska, B ;
Burger, C ;
Winkler, C ;
Muzyczka, N ;
Mandel, RJ ;
Björklund, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (07) :4708-4713
[25]   Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism [J].
Kitada, T ;
Asakawa, S ;
Hattori, N ;
Matsumine, H ;
Yamamura, Y ;
Minoshima, S ;
Yokochi, M ;
Mizuno, Y ;
Shimizu, N .
NATURE, 1998, 392 (6676) :605-608
[26]   Measurements of vector-derived neurotrophic factor and green fluorescent protein levels in the brain [J].
Klein, RL ;
Hamby, ME ;
Sonntag, CF ;
Millard, WJ ;
King, MA ;
Meyer, EM .
METHODS, 2002, 28 (02) :286-292
[27]   Dopaminergic cell loss induced by human A30P α-synuclein gene transfer to the rat substantia nigra [J].
Klein, RL ;
King, MA ;
Hamby, ME ;
Meyer, EM .
HUMAN GENE THERAPY, 2002, 13 (05) :605-612
[28]   Dose and promoter effects of adeno-associated viral vector for green fluorescent protein expression in the rat brain [J].
Klein, RL ;
Hamby, ME ;
Gong, Y ;
Hirko, AC ;
Wang, S ;
Hughes, JA ;
King, MA ;
Meyer, EM .
EXPERIMENTAL NEUROLOGY, 2002, 176 (01) :66-74
[29]   Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease [J].
Kordower, JH ;
Emborg, ME ;
Bloch, J ;
Ma, SY ;
Chu, YP ;
Leventhal, L ;
McBride, J ;
Chen, EY ;
Palfi, S ;
Roitberg, BZ ;
Brown, WD ;
Holden, JE ;
Pyzalski, R ;
Taylor, MD ;
Carvey, P ;
Ling, ZD ;
Trono, D ;
Hantraye, P ;
Déglon, N ;
Aebischer, P .
SCIENCE, 2000, 290 (5492) :767-773
[30]   Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease [J].
Krüger, R ;
Kuhn, W ;
Müller, T ;
Woitalla, D ;
Graeber, M ;
Kösel, S ;
Przuntek, H ;
Epplen, JT ;
Schöls, L ;
Riess, O .
NATURE GENETICS, 1998, 18 (02) :106-108